• Publications
  • Influence

Claim Your Author Page
Ensure your research is discoverable on Semantic Scholar. Claiming your author page allows you to personalize the information displayed and manage your publications. Semantic Scholar automatically creates author pages based on data aggregated from public sources and our publisher partners.
  • Thomas Strowitzki, Joachim Marr, Christoph Gerlinger, Thomas Faustmann, C Seitz
  • Medicine
  • Human reproduction
  • 2010 (First Publication: 1 March 2010)
  • BACKGROUND Dienogest is a selective progestin that has been investigated in a clinical trial programme for the treatment of endometriosis. The current non-inferiority trial compared the efficacy andContinue Reading
  • Anne B. Zimmermann, David Bernuit, Christoph Gerlinger, Matthias Schaefers, Katharina Geppert
  • Medicine
  • BMC Women's Health
  • 2012 (First Publication: 26 March 2012)
  • BackgroundIn 2009 the Uterine Bleeding and Pain Women's Research Study (UBP-WRS) was conducted interviewing 21,479 women across 8 countries in order to gain patient-based prevalence data on uterineContinue Reading
  • Jean Michel Foidart, Wolfgang Wuttke, Gerrit Bouw, Christoph Gerlinger, Renate Heithecker
  • Medicine
  • The European journal of contraception…
  • 2000
  • OBJECTIVE To assess the contraceptive reliability, cycle control and tolerance of a new monophasic oral contraceptive (Yasmin) containing 30 microg ethinylestradiol and 3 mg drospirenone and compareContinue Reading
  • Thomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, Christian Seitz
  • Medicine
  • European journal of obstetrics, gynecology, and…
  • 2010 (First Publication: 1 August 2010)
  • OBJECTIVE To investigate the efficacy and safety of oral dienogest 2mg compared with placebo in the treatment of endometriosis-associated pelvic pain (EAPP). STUDY DESIGN This was a 12-week,Continue Reading
  • Johannes C. Huber, Jean Michel Foidart, +5 authors Renate Heithecker
  • Medicine
  • The European journal of contraception…
  • 2000 (First Publication: 1 January 2000)
  • Objective To assess the contraceptive reliability, cycle control and tolerability of a new monophasic oral contraceptive containing 30 g ethinylestradiol plus 3 mg drospirenone (Yasmin, Schering AG,Continue Reading
  • Christoph Gerlinger, Ulrike Schumacher, Thomas Faustmann, Antje Colligs, Heinz Schmitz, Christian Seitz
  • Medicine
  • Health and quality of life outcomes
  • 2010 (First Publication: 24 November 2010)
  • BackgroundWhen comparing active treatments, a non-inferiority (or one-sided equivalence) study design is often used. This design requires the definition of a non-inferiority margin, the thresholdContinue Reading